LAUSR

OBJECTIVES To investigate methodological quality of published dose-response meta-analysis (DRMA) and explore study characteristics associated with the quality. STUDY DESIGN AND SETTING We searched three databases for published DRMAs and used a modified AMSTAR (15 items) checklist to assess the methodological quality. We summarized the compliance of those DRMAs to the AMSTAR items and used multivariable regression analysis to explore the association between prespecified study characteristics with the overall methodological quality. RESULTS We identified 529 DRMAs. Of the methodological quality items, six were well complied (80% or more) and six poorly complied (30% or fewer) by these DRMAs. The median score was nine points [first and third quartile: 7, 10] and only 64/529 had score over 10 points. Regression analysis suggested that studies with more authors (β = 0.19; 95% confidence interval [CI]: 0.05, 0.33), published more recently (β = 0.29; 95% CI: 0.21, 0.36), with financial support (β = 0.41; 95% CI: 0.13, 0.70), conducted by authors from European (other regions vs. European, β = -0.68; 95% CI: -1.05, -0.31) were associated with better methodological quality. CONCLUSION The methodological quality of published DRMAs was suboptimal. Substantial efforts are warranted to improve the quality, including developing methodology guideline, involving more methodological trained authors, and so forth.